INSMED INC Accrued Liabilities, Current
INSMED INC (INSM) had Accrued Liabilities, Current of $58.77 million as of 2022-06-30, per its 10-Q filed 2022-08-04.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2022-08-04
- 2022-06-30: Accrued Liabilities, Current $58.77M.
- 2022-03-31: Accrued Liabilities, Current $53.29M.
- 2021-12-31: Accrued Liabilities, Current $60.66M.
- 2021-09-30: Accrued Liabilities, Current $62.27M.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2022-06-30 | $58.77M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $53.29M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $60.66M 10-Q · filed 2022-08-04 | |
| 2021-09-30 | $62.27M 10-Q · filed 2021-10-28 | |
| 2021-06-30 | $45.55M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $41.29M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $37.81M 10-K · filed 2022-02-17 | |
| 2020-09-30 | $35.15M 10-Q · filed 2020-10-29 | |
| 2020-06-30 | $31.92M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $32.69M 10-Q · filed 2020-04-30 | |
| 2019-12-31 | $40.38M 10-K · filed 2021-02-25 | |
| 2019-09-30 | $38.91M 10-Q · filed 2019-10-30 | |
| 2019-06-30 | $49.36M 10-Q · filed 2019-08-01 | |
| 2019-03-31 | $38.32M 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $38.25M 10-K · filed 2020-02-25 | |
| 2018-09-30 | $40.37M 10-Q · filed 2018-10-30 | |
| 2018-06-30 | $29.05M 10-Q · filed 2018-08-02 | |
| 2018-03-31 | $21.07M 10-Q · filed 2018-05-02 | |
| 2017-12-31 | $17.14M 10-K · filed 2019-02-22 | $29.34M 10-K · filed 2018-02-23 |
| 2017-09-30 | $18.80M 10-Q · filed 2017-11-02 | |
| 2017-06-30 | $14.55M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $14.14M 10-Q · filed 2017-05-03 | |
| 2016-12-31 | $16.82M 10-K · filed 2018-02-23 | |
| 2016-09-30 | $14.53M 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $13.51M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $10.49M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $10.99M 10-K · filed 2017-02-23 | |
| 2015-09-30 | $9.90M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $6.01M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $5.98M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $9.64M 10-K · filed 2016-02-25 | $5.32M 10-K · filed 2015-02-27 |
| 2014-09-30 | $3.55M 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $4.55M 10-Q · filed 2014-08-06 | |
| 2014-03-31 | $3.14M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $3.90M 10-K · filed 2015-02-27 | |
| 2013-09-30 | $5.65M 10-Q · filed 2013-11-05 | |
| 2013-06-30 | $3.19M 10-Q · filed 2013-08-06 | |
| 2013-03-31 | $5.33M 10-Q · filed 2013-05-07 | |
| 2012-12-31 | $2.93M 10-K · filed 2014-03-06 | |
| 2012-09-30 | $836.00K 10-Q · filed 2012-11-07 | |
| 2012-06-30 | $1.88M 10-Q · filed 2012-08-07 | |
| 2012-03-31 | $193.00K 10-Q · filed 2012-05-08 | |
| 2011-12-31 | $800.00K 10-K · filed 2013-03-18 | |
| 2011-09-30 | $1.55M 10-Q · filed 2011-11-09 | |
| 2011-06-30 | $1.16M 10-Q/A · filed 2011-08-08 | |
| 2010-12-31 | $139.00K 10-K · filed 2012-03-13 | $1.26M 10-Q/A · filed 2011-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |